Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis

European Journal of Heart Failure

Volumn 3, Issue 1, 2001, Pages 15-19

  Talwar, Suneel ^a   Downie, Paul F ^a   Squire, Iain B ^a   Davies, Joan E ^a   Barnett, David B ^a   Ng, Leong L ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aortic stenosis; Brain natriuretic peptide; Cardiotrophin 1; Echocardiography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARDIOTROPHIN 1; CYTOKINE; HORMONE PRECURSOR;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AORTA STENOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; HEART STRESS; HEART VENTRICLE CONTRACTION; HUMAN; MALE; PRESSURE GRADIENT; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; CYTOKINES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; STATISTICS, NONPARAMETRIC;

EID: 0035143708     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00074-X     Document Type: Article

References (22)

1. Pathology of aortic vane stenosis and pure aortic regurgitation: A clinical morphological assessment
2. Brain natriuretic peptide as a novel cardiac hormone in humans
3. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide
4. Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
5. Plasma levels of brain natriuretic peptide and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis
6. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma
7. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy
8. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats
9. Cardiotrophin-1, A new agonist for a gp-130 signalling pathway, stimulates brain natriuretic peptide (BNP) secretion more abundantly than endothelin-1 (ET-1)
10. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction
11. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multicentre studies
12. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis
13. Non-invasive assessment of aortic stenosis by Doppler ultrasound
14. Comparison of Doppler derived pressure gradients to that determined at cardiac catheterisation in adults with aortic valve stenosis. Implications for management
15. An immunoluminometric assay (ILMA) for N-terminal proBNP: Development of a test for left ventricular dysfunction
16. An immunoluminometric assay for cardiotrophin-1: A newly identified cytokine is present in normal human plasma and is increased in heart failure
17. Acridinium esters as high specific-activity labels in immunoassay
18. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes
19. Plasma N-terminal pro-brain natriuretic peptide in the assessment of left-ventricular systolic dysfunction in a high risk (hospital) population
20. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
21. Plasma cardiotrophin-1 levels following myocardial infarction and the relationship with ventricular dysfunction